I'm not expecting to hear the MASH study results right away. I expect data collection will happen first, then the analysis. I do believe only Cytodyn owns this data and they will control it for the benefit of the company. The current team has been delivering on goals this year and we know from a June press release that they will use this data to pursue partnerships in MASH. I trust them in using and announcing the data in a sensible manner.